🔗 Permalink

Inventor profile of:

Michael Ankersen

City:

Stenlose

Country:

Denmark

Published Applications:

Last publication date:

2011-12-08

Top Assignees for applications by Michael Ankersen

The entities that hold a legal rights for patent applications filed by inventor Ankersen Michael:

Novo Nordisk A/S 10 Bagsvaerd, Denmark
TRANSTECH PHARMA, INC. 2 High Point, NC United States

Recent patent applications by Ankersen Michael

Michael Ankersen from Stenlose, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2011-12-08

US20110301158A1

Chemistry; metallurgy

ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS

#2 | 2011-04-07

US20110082144A1

Chemistry; metallurgy

N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes

#3 | 2011-03-10

US20110060019A1

Chemistry; metallurgy

Heteroaryl-ureas and their use as glucokinase activators

#4 | 2010-08-12

US20100204288A1

Chemistry; metallurgy

Heteroaryl-ureas and their use as glucokinase activators

#5 | 2009-08-27

US20090216013A1

Chemistry; metallurgy

Heteroaryl-ureas and their use as glucokinase activators

#6 | 2008-06-10

US10679887

Aryl carbonyl derivatives as therapeutic agents

#7 | 2008-05-22

US20080119455A1

Chemistry; metallurgy

Aryl carbonyl derivatives as therapeutic agents

#8 | 2008-05-22

US20080119454A1

Chemistry; metallurgy

Aryl carbonyl derivatives as therapeutic agents

#9 | 2007-08-09

US20070185128A1

Chemistry; metallurgy

Compounds and compositions for treating obesity

#10 | 2007-03-08

US20070054897A1

Chemistry; metallurgy

Heteroaryl-ureas and their use as glucokinase activators

#11 | 2007-02-01

US20070027140A1

Chemistry; metallurgy

N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes

#12 | 2006-08-17

US20060183783A1

Chemistry; metallurgy

Aryl carbonyl derivatives as therapeutic agents

InventorID:

3491648 ⎘